13D/G large-stake feed

Latest 13D/G Reports

Since 04 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G/A

Alyeska Investment Group, L.P. stake in ESS Tech, Inc.

Holder CIK 0001453072

13G/A GWH
CIK
0001453072
Issuer
ESS Tech, Inc.
Security
GWH
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5.2% / 1,400,000 shares
Filed
15 May 2026, 16:33:12 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Venrock Healthcare Capital Partners III, L.P. stake in Surrozen, Inc.

Holder CIK 0001738048

13G/A SRZN
CIK
0001738048
Issuer
Surrozen, Inc./DE
Security
SRZN
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
9.9% / 1,205,000 shares
Filed
15 May 2026, 16:32:52 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

Pentwater Capital Management LP stake in The GEO Group Inc.

Holder CIK 0001425851

13G GEO
CIK
0001425851
Issuer
GEO GROUP INC
Security
GEO
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
7.2% / 9,615,000 shares
Filed
15 May 2026, 16:32:44 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

Alyeska Investment Group, L.P. stake in GPGI, Inc.

Holder CIK 0001453072

13G GPGI
CIK
0001453072
Issuer
GPGI, Inc.
Security
GPGI
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
7.4% / 21,395,253 shares
Filed
15 May 2026, 16:32:31 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

Nantahala Capital Partners Limited Partnership stake in ABEONA THERAPEUTICS INC.

Holder CIK 0001502725

13G/A ABEO
CIK
0001502725
Issuer
ABEONA THERAPEUTICS INC.
Security
ABEO
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
5.8% / 3,333,757 shares
Filed
15 May 2026, 16:32:28 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

RA CAPITAL MANAGEMENT, L.P. stake in Atrium Therapeutics, Inc.

Holder CIK 0001346824

13G RNA
CIK
0001346824
Issuer
Atrium Therapeutics, Inc.
Security
RNA
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
5.6% / 864,102 shares
Filed
15 May 2026, 16:32:28 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
801-850 of 4,031
Per page
50
Current page
17

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

0/6

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

9.9%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

Alyeska Investment Group, L.P.

ESS Tech, Inc. (GWH)

Schedule 13G/A Ownership 5.2% Filing-backed
CIK
000117266126002362
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
5.2%
Filed
15 May 2026, 16:33:12 UTC
Period
31 Mar 2026

Alyeska Investment Group, L.P. filed Schedule 13G/A for ESS Tech, Inc. (GWH). Reported class ownership: 5.2%. Ownership change: -2%. Share change: 0%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Venrock Healthcare Capital Partners III, L.P.

Surrozen, Inc. (SRZN)

Schedule 13G/A Ownership 9.9% Filing-backed
CIK
000173804826000056
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
9.9%
Filed
15 May 2026, 16:32:52 UTC
Period
31 Mar 2026

Venrock Healthcare Capital Partners III, L.P. filed Schedule 13G/A for Surrozen, Inc. (SRZN). Reported class ownership: 9.9%. Ownership change: 0%. Share change: +38%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Pentwater Capital Management LP

The GEO Group Inc. (GEO)

Schedule 13G Ownership 7.2% Filing-backed
CIK
000090266426002536
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
7.2%
Filed
15 May 2026, 16:32:44 UTC
Period
31 Mar 2026

Pentwater Capital Management LP filed Schedule 13G for The GEO Group Inc. (GEO). Reported class ownership: 7.2%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Alyeska Investment Group, L.P.

GPGI, Inc. (GPGI)

Schedule 13G Ownership 7.4% Filing-backed
CIK
000117266126002361
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
7.4%
Filed
15 May 2026, 16:32:31 UTC
Period
31 Mar 2026

Alyeska Investment Group, L.P. filed Schedule 13G for GPGI, Inc. (GPGI). Reported class ownership: 7.4%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Nantahala Capital Partners Limited Partnership

ABEONA THERAPEUTICS INC. (ABEO)

Schedule 13G/A Ownership 5.8% Filing-backed
CIK
000110465926062655
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
5.8%
Filed
15 May 2026, 16:32:28 UTC
Period
31 Mar 2026

Nantahala Capital Partners Limited Partnership filed Schedule 13G/A for ABEONA THERAPEUTICS INC. (ABEO). Reported class ownership: 5.8%. Ownership change: +0.73%. Share change: +27%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

RA CAPITAL MANAGEMENT, L.P.

Atrium Therapeutics, Inc. (RNA)

Schedule 13G Ownership 5.6% Filing-backed
CIK
000134682426000145
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
5.6%
Filed
15 May 2026, 16:32:28 UTC
Period
31 Mar 2026

RA CAPITAL MANAGEMENT, L.P. filed Schedule 13G for Atrium Therapeutics, Inc. (RNA). Reported class ownership: 5.6%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
Alyeska Investment Group, L.P. CIK 0001453072 GWH ESS Tech, Inc. 1,400,000 5.2% SEC filing
Venrock Healthcare Capital Partners III, L.P. CIK 0001738048 SRZN Surrozen, Inc. 1,205,000 9.9% SEC filing
Pentwater Capital Management LP CIK 0001425851 GEO The GEO Group Inc. 9,615,000 7.2% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 GPGI GPGI, Inc. 21,395,253 7.4% SEC filing
Nantahala Capital Partners Limited Partnership CIK 0001502725 ABEO ABEONA THERAPEUTICS INC. 3,333,757 5.8% SEC filing
RA CAPITAL MANAGEMENT, L.P. CIK 0001346824 RNA Atrium Therapeutics, Inc. 864,102 5.6% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 XON PRECIGEN, INC. 6,741,861 1.9% SEC filing
Pentwater Capital Management LP CIK 0001425851 CNTA Centessa Pharmaceuticals plc 8,170,000 5.3% SEC filing
ORBIMED ADVISORS LLC CIK 0001055951 AVTX Avalo Therapeutics, Inc. 475,165 2.1% SEC filing
Lynx1 Capital Management LP CIK 0001910456 ALLO Allogene Therapeutics, Inc. 0 0% SEC filing
Venrock Healthcare Capital Partners III, L.P. CIK 0001738048 TENX Tenax Therapeutics, Inc. 1,955,105 9.9% SEC filing
Sachem Head Capital Management LP CIK 0001582090 SHC Sotera Health Co 15,560,000 5.5% SEC filing
Canada Growth Fund Inc. CIK 0002049820 NMG Nouveau Monde Graphite Inc. 84,134,998 24% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 FTW PRESIDIO PRODUCTION COMPANY 2,717,391 9.8% SEC filing
Pentwater Capital Management LP CIK 0001425851 EA Electronic Arts Inc. 12,807,500 5.1% SEC filing
First Trust Capital Management L.P. CIK 0001604488 VNME Vendome Acquisition Corp I 1,092,788 5.5% SEC filing
Fairmount Funds Management LLC CIK 0001802528 ELVN ENLIVEN THERAPEUTICS, INC. 1,855,644 3.1% SEC filing
TENOR CAPITAL MANAGEMENT Co., L.P. CIK 0001346554 FACTU FACT II Acquisition Corp. 1,500,000 8.1% SEC filing
Lynx1 Capital Management LP CIK 0001910456 GHRS GH Research PLC 9,456,622 15% SEC filing
MMCAP International Inc. SPC CIK 0001304857 EU enCore Energy Corp. 8,874,682 4.5% SEC filing
Commodore Capital LP CIK 0001831942 ELVN Enliven Therapeutics, Inc. 4,800,940 7.7% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 DUOT DUOS TECHNOLOGIES GROUP, INC. 1,906,659 6.4% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 KRRO Korro Bio, Inc. 0 0% SEC filing
MMCAP International Inc. SPC CIK 0001304857 WSTRF Western Uranium & Vanadium Corp. 3,705,367 5% SEC filing
Venrock Healthcare Capital Partners III, L.P. CIK 0001738048 VOR VOR BIOPHARMA INC. 5,083,877 9.9% SEC filing
Carlyle Group Inc. CIK 0001527166 SARO StandardAero, Inc. 84,587,035 25% SEC filing
Carlyle Group Inc. CIK 0001527166 MDLN Medline Inc. 187,083,713 21% SEC filing
Brookfield Oaktree Holdings, LLC CIK 0001403528 BATL Battalion Oil Corporation 12,437,521 41% SEC filing
Aldabra 4 LOV Sponsor Partnership, LLC CIK 0002107769 ALOVW Aldabra 4 Liquidity Opportunity Vehicle, Inc. 7,398,750 20% SEC filing
Lynx1 Capital Management LP CIK 0001910456 STOK Stoke Therapeutics, Inc. 4,121,244 7% SEC filing
DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP CIK 0001854440 FUN Six Flags Entertainment Corporation/NEW 8,700,000 8.5% SEC filing
Nantahala Capital Partners Limited Partnership CIK 0001502725 KPRX KIORA PHARMACEUTICALS, INC. 148,736 3.4% SEC filing
RA CAPITAL MANAGEMENT, L.P. CIK 0001346824 FDMT 4D MOLECULAR THERAPEUTICS, INC. 5,105,622 9.9% SEC filing
BCPE BDF Investor, LP CIK 0002085166 BOBS Bob's Discount Furniture, Inc. 95,370,751 73% SEC filing
BCLS Fund III Investments, LP CIK 0001952107 HTFL Heartflow, Inc. 10,448,158 12% SEC filing
Cross Ocean Partners Management LP CIK 0001752226 KLXE KLX Energy Services Holdings, Inc. 745,122 3.7% SEC filing
M33 Growth I L.P. CIK 0001718621 TOI Oncology Institute, Inc. 5,002,656 4.9% SEC filing
SC US (TTGP), LTD. CIK 0001607841 LIFE Ethos Technologies Inc. 11,857,508 28% SEC filing
BLATT LAWRENCE CIK 0001242110 ALGS Aligos Therapeutics, Inc. 286,213 5.1% SEC filing
Bain Capital Life Sciences Opportunities IV, L.P. CIK 0002015553 OLMA OLEMA PHARMACEUTICALS, INC. 7,473,238 8.2% SEC filing
Bain Capital Life Sciences Fund II, L.P. CIK 0001773187 XLO Xilio Therapeutics, Inc. 664,021 10% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 TENX TENAX THERAPEUTICS, INC. 533,965 3.1% SEC filing
PACIFIC INVESTMENT MANAGEMENT CO LLC CIK 0001163368 VG Venture Global, Inc. 251,315,622 49% SEC filing
MMCAP International Inc. SPC CIK 0001304857 ARIS Aris Mining Corporation 7,815,142 3.8% SEC filing
Alyeska Investment Group, L.P. CIK 0001453072 DFLI Dragonfly Energy Holdings Corp. 750,270 6.2% SEC filing
Stoney Lonesome HF LP CIK 0002014854 HCAT Health Catalyst, Inc. 6,308,345 8.6% SEC filing
MMCAP International Inc. SPC CIK 0001304857 ASTL Algoma Steel Group Inc. 12,845,622 12% SEC filing
Coliseum Capital Management, LLC CIK 0001409751 MBC MasterBrand, Inc. 12,694,710 9.9% SEC filing
Point72 Asset Management, L.P. CIK 0001603466 FBRX Forte Biosciences, Inc. 0 0% SEC filing
MMCAP International Inc. SPC CIK 0001304857 CRDL Cardiol Therapeutics Inc. 21,063,856 18% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .